Combined Modality Therapy of Central Nervous System Tumors (Paperback, Softcover reprint of the original 1st ed. 2003)

The American Cancer Society anticipates that 16,500 patients will be diagnosed with primary malignant tumors of the central nervous system in 2000, with about 200,000 individuals presenting with brain metastases. The advances in the treatment of solid tumors have contributed significantly to the major increase in metastatic cancers to the brain. Of the primary malignant tumors of the brain, more than 50% are high-grade gliomas; the incidence has been increasing among older patients over the past decade. Major developments in new technologies in the treatment of primary brain tumors as well as metastatic disease are covered in depth. Even though management is difficult, advances are being made. This book is a concerted effort to present data regarding basic science research efforts alongside their translation into clinical practice using combined, integrated multimodal programs of treatment. Progress has been made, but innovatice approaches need to be pursued.

General

Imprint:	Springer-Verlag
Country of origin:	Germany
Series:	Radiation Oncology
Release date:	April 2003
First published:	2003
Editors:	Zbigniew Petrovich
Foreword by:	L.W. Brady
Editors:	Luther W. Brady
Foreword by:	H.-P. Heilmann • M. Molls
Editors:	Michael L.J. Apuzzo • Michael Bamberg
Dimensions:	270 x 193 x 35mm (L x W x T)
Format:	Paperback
Pages:	640
Edition:	Softcover reprint of the original 1st ed. 2003
ISBN-13:	978-3-540-00627-5
Categories:	Books > Medicine > Clinical & internal medicine > Neurology & clinical neurophysiology Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > General
LSN:	3-540-00627-3
Barcode:	9783540006275

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!